LRMR

NASD Larimar Therapeutics, Inc.
Oct 9, 2026 · 1:43 AM ET EOD Market Closed

$2.70 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.70, $0.04 below the day’s high of $2.74

YTD change
-29.13%
vs 20-day SMA
-21.52%
vs 200-day SMA
-31.03%

Price ranges

Previous day
$2.72 $2.84
open $2.77 close $2.75
-$0.02 (-0.72%)
Today
$2.61 $2.74
open $2.72 now $2.70
-$0.02 (-0.74%)
Past week
$2.72 $3.20
from $3.20 now $2.70
-$0.50 (-15.49%)
Past month
$2.72 $4.12
from $3.87 now $2.70
-$1.17 (-30.23%)
This year
$2.61 $6.42
from $3.81 now $2.70
-$1.11 (-29.13%)

Price & Performance

-2.39 (-46.95%) / 6M

$2.51$3.43$4.36$5.28Apr 8Jul 9Oct 8

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 89.6% away from all-time highs of $25.87
  • LRMR is down 29% since the beginning of the year
  • LRMR is down 44% over the past 12 months
  • LRMR is down 30% over the past 1 month
  • 17% of all LRMR investors are betting against LRMR

LRMR reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -44.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.3
Earnings momentum +14.5% Quarterly EPS growth
Quarterly change +14.5%

Valuation

P/E ratio N/A
Enterprise value $135.7M
Beta 1.78

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$156.3M
Debt$5.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $280.5M

Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing treatments for patients suffering from complex rare diseases using a novel cell penetrating peptide technology platform. It also engages in the research, development, and commercialization of novel therapeutics for mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $407.44 -1.37%
MRNA Moderna, Inc. $197.00 +0.26%
RVMD Revolution Medicines, Inc. $188.12 -6.35%
ROIV Roivant Sciences Ltd. $34.21 -1.55%
BNTX BioNTech SE Sponsored ADR $92.06 -3.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.